Daniel Ramirez

Daniel Ramirez is a seasoned professional in venture capital, corporate venture building, and innovation, with a robust focus on investing in transformative platforms across North America and Europe. Previously, they held leadership roles at LEO Pharma, where they spearheaded the Business Strategy & Innovation team and contributed significantly to the LEO Innovation Lab's development. Daniel has also served on the boards of various organizations, including Pacifica Labs Inc. and Remedly, and is currently an investor with Myriad AI and a founding partner at Ten VC. Their academic background includes an MBA from IESE Business School and executive education at MIT Sloan and Harvard Medical School.